Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Kindeva Drug Delivery LP
483
•Kindeva Drug Delivery LP•November 13, 2025

Kindeva Drug Delivery LP – FDA 483, Nov 13, 2025

Record Details

During an inspection conducted from November 3 to November 13, 2025, the FDA issued a Form 483 to Kindeva Drug Delivery L.P. The observations highlight significant deficiencies in manufacturing process controls and quality system documentation. The first observation details a lack of adequate control procedures to monitor manufacturing processes and validate their performance, particularly concerning Critical Control Points (CCPs). The company's manufacturing equipment lacks continuous automated monitoring, real-time alarm capabilities, and data recording for critical parameters, with reliance on periodic manual checks deemed insufficient to detect deviations. This affects a substantial volume of product manufacturing monthly. The second observation notes a failure to investigate and document discrepancies in the microbial testing method for water used in equipment cleaning. Inspectors observed systematic deficiencies in the testing apparatus that could compromise the reliability of test results, yet no formal investigation or corrective action was documented. This prevents the verification of water quality against established specifications, critical for equipment cleanliness and product integrity. These observations indicate that Kindeva Drug Delivery L.P. must implement robust corrective and preventive actions to ensure compliance with good manufacturing practices, specifically by enhancing process monitoring and control systems and establishing a comprehensive discrepancy investigation and documentation process, as required by the Federal Food, Drug and Cosmetic Act.

Company
Kindeva Drug Delivery LP
Inspection date
November 13, 2025
Product type
drugs
Office
Los Angeles District Office
People
  • Darren S. Brown (Consumer Safety Officer)
  • Taichun Qin (Consumer Safety Officer, Drug Specialist)
  • Tiara M. Brown (Consumer Safety Officer)
View Company Profile

ID · 772d01d4-412d-4ee3-b9bb-0bc89003aeeb

Other documents for Kindeva Drug Delivery LP
  • 483 - 2024-04-03April 3, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kindeva Drug Delivery LP
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.